Concepedia

Morphologic Risk Stratification

Morphologic Risk Stratification is a clinical assessment framework that categorizes ovarian cysts based on distinctive microscopic and structural features to differentiate benign from malignant lesions according to their histopathological architecture.

41

Publications

2.9K

Citations

275

Authors

111

Institutions

Publications per year

2017–2026

4

Parents

Publications

41

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

Ignace Vergote, Jos De Brabanter, Anthony Fyles et al. · The Lancet · 2001 · 627 citations

, , +16

“Malignant” Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies

Jonathan Bleeker, J. Fernando Quevedo, Andrew L. Folpe · Sarcoma · 2012 · 211 citations · Full text

, , +16

A Morphology Index Based on Sonographic Findings in Ovarian Cancer

Paul D. DePriest, Douglas Shenson, Andrew M. Fried et al. · Gynecologic Oncology · 1993 · 203 citations

, , +16

Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy

John M. Kurtz, Jocelyne Jacquemier, H Brandone et al. · Cancer · 1990 · 197 citations

, , +15

Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk Criteria

Brian K. P. Goh, Pierce K. H. Chow, Wai-Ming Yap et al. · Annals of Surgical Oncology · 2008 · 116 citations

, , +13

1–5 of 41

Authors

275

  1. JP
    Jan P. A. Baak

    Stavanger University Hospital, Norway

    3 publications · 162 citations

    3

    h-index

  2. PB
    P.D. Bezemer

    University of Amsterdam, Netherlands

    2 publications · 109 citations

    2

    h-index

  3. FA
    F. A. Langley

    University of Manchester, United Kingdom

    2 publications · 111 citations

    2

    h-index

  4. RJ
    Richard J. Kryscio

    University of Kentucky, United States

    2 publications · 258 citations

    2

    h-index

  5. JR
    John R. van Nagell

    University of Kentucky, United States

    2 publications · 258 citations

    2

    h-index

1–5 of 275

Institutions

111

  1. University of Amsterdam

    Amsterdam, The Netherlands

    3 h-index

    8 publications

    474 citations

  2. Johns Hopkins University

    Baltimore, United States

    2 h-index

    6 publications

    280 citations

  3. National Cancer Institute

    Bethesda, United States

    2 h-index

    2 publications

    99 citations

  4. Princess Margaret Cancer Centre

    Toronto, Canada

    2 h-index

    5 publications

    667 citations

  5. Harvard University

    Cambridge, United States

    2 h-index

    8 publications

    180 citations

  6. Mayo Clinic in Arizona

    Scottsdale, United States

    2 h-index

    5 publications

    674 citations

  7. Mayo Clinic

    Rochester, United States

    2 h-index

    11 publications

    1.1K citations

  8. University of Michigan

    Ann Arbor, United States

    2 h-index

    2 publications

    48 citations

1–8 of 111

Venues

  1. Gynecologic Oncology

    5 publications · 381 citations

    5

    h-index

  2. PubMed

    Repository · 3 publications · 152 citations

    3

    h-index

  3. European Radiology

    3 publications · 77 citations

    3

    h-index

  4. 2

    h-index

  5. International Journal of Gynecological Cancer

    2 publications · 30 citations

    2

    h-index

1–5